Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model: Spectroscopic changes precede morphologic changes

Lezlee Coghlan, Urs Utzinger, Rebecca Richards-Kortum, Carrie Brookner, Andres Zuluaga, Irma Gimenez-Conti, Michele Follen

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background and Objective: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[α]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. Study Design/Materials and Methods: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. Results: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95% sensitivity and 93% specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. Conclusions: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalLasers in Surgery and Medicine
Volume29
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Fluorescence Spectrometry
Epithelium
Animal Models
Fluorescence
Carcinoma
Cheek
Cricetinae
Hyperplasia
Carcinogenesis
Sensitivity and Specificity
anthracene

Keywords

  • DMBA
  • Fluorescence
  • Spectrometry
  • Syrian hamster

ASJC Scopus subject areas

  • Surgery

Cite this

Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model : Spectroscopic changes precede morphologic changes. / Coghlan, Lezlee; Utzinger, Urs; Richards-Kortum, Rebecca; Brookner, Carrie; Zuluaga, Andres; Gimenez-Conti, Irma; Follen, Michele.

In: Lasers in Surgery and Medicine, Vol. 29, No. 1, 2001, p. 1-10.

Research output: Contribution to journalArticle

Coghlan, Lezlee ; Utzinger, Urs ; Richards-Kortum, Rebecca ; Brookner, Carrie ; Zuluaga, Andres ; Gimenez-Conti, Irma ; Follen, Michele. / Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model : Spectroscopic changes precede morphologic changes. In: Lasers in Surgery and Medicine. 2001 ; Vol. 29, No. 1. pp. 1-10.
@article{8c96808130db46519d72fa3444590df0,
title = "Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model: Spectroscopic changes precede morphologic changes",
abstract = "Background and Objective: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[α]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. Study Design/Materials and Methods: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. Results: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95{\%} sensitivity and 93{\%} specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. Conclusions: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections.",
keywords = "DMBA, Fluorescence, Spectrometry, Syrian hamster",
author = "Lezlee Coghlan and Urs Utzinger and Rebecca Richards-Kortum and Carrie Brookner and Andres Zuluaga and Irma Gimenez-Conti and Michele Follen",
year = "2001",
doi = "10.1002/lsm.1078",
language = "English (US)",
volume = "29",
pages = "1--10",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model

T2 - Spectroscopic changes precede morphologic changes

AU - Coghlan, Lezlee

AU - Utzinger, Urs

AU - Richards-Kortum, Rebecca

AU - Brookner, Carrie

AU - Zuluaga, Andres

AU - Gimenez-Conti, Irma

AU - Follen, Michele

PY - 2001

Y1 - 2001

N2 - Background and Objective: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[α]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. Study Design/Materials and Methods: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. Results: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95% sensitivity and 93% specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. Conclusions: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections.

AB - Background and Objective: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[α]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. Study Design/Materials and Methods: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. Results: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95% sensitivity and 93% specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. Conclusions: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections.

KW - DMBA

KW - Fluorescence

KW - Spectrometry

KW - Syrian hamster

UR - http://www.scopus.com/inward/record.url?scp=0034904153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034904153&partnerID=8YFLogxK

U2 - 10.1002/lsm.1078

DO - 10.1002/lsm.1078

M3 - Article

C2 - 11500855

AN - SCOPUS:0034904153

VL - 29

SP - 1

EP - 10

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 1

ER -